Case - Long-term management of oligo-progressive metastatic castrate sensitive prostate cancer with recurrence-directed radiotherapy

RDT includes stereotactic body radiation therapy (SBRT) to precisely deliver high-dose radiation to metastatic sites with or without concomitant systemic therapy, elective nodal irradiation, and surgery.SBRT has shown promising efficacy in managing oligometastatic disease in various cancer types.This case report details a patient with CSPC who presented with episodes of oligoprogression, resisted treatment with standard of care ADT over a period of 9 years, and was managed with nine courses of RDT with limited ADT.It highlights the potential of RDT in addressing some therapeutic challenges posed by progressing metastatic PC.

Authors

Institutions

Publication Details

Journal
Canadian Urological Association Journal
Published
2025-11-25
DOI
https://doi.org/10.5489/cuaj.9363
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case - Long-term management of oligo-progressive metastatic castrate sensitive prostate cancer with recurrence-directed radiotherapy

Theodoros Tsakiridis, Shan Grewal, Hsin‐pei Hu, André G. Gouveia
Canadian Urological Association Journal
Prostate Cancer Treatment and Research
article

Case - Long-term management of oligo-progressive metastatic castrate sensitive prostate cancer with recurrence-directed radiotherapy

Theodoros Tsakiridis, Shan Grewal, Hsin‐pei Hu, André G. Gouveia
article en

Abstract

RDT includes stereotactic body radiation therapy (SBRT) to precisely deliver high-dose radiation to metastatic sites with or without concomitant systemic therapy, elective nodal irradiation, and surgery.SBRT has shown promising efficacy in managing oligometastatic disease in various cancer types.This case report details a patient with CSPC who presented with episodes of oligoprogression, resisted treatment with standard of care ADT over a period of 9 years, and was managed with nine courses of RDT with limited ADT.It highlights the potential of RDT in addressing some therapeutic challenges posed by progressing metastatic PC.

Canadian Urological Association JournalVol. 20(3)
Juravinski Cancer Centre (CA), McMaster University (CA)
Openalex Percentile: Top 45%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.